Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation

Sirolimus is an effective agent used in graft-versus-host disease (GVHD) prophylaxis after allogeneic transplantation. It also has antiproliferative effects on vascular endothelium when used to coat coronary artery stents. We noted an excess of veno-occlusive disease (VOD) in a clinical trial, and r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cutler, Corey, Stevenson, Kristen, Kim, Haesook T., Richardson, Paul, Ho, Vincent T., Linden, Erica, Revta, Carolyn, Ebert, Ruth, Warren, Diane, Choi, Sung, Koreth, John, Armand, Philippe, Alyea, Edwin, Carter, Shelly, Horowitz, Mary, Antin, Joseph H., Soiffer, Robert
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597119/
https://ncbi.nlm.nih.gov/pubmed/18776081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-169342
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars